San Diego, CA, United States of America

Mingwei Chen



 

Average Co-Inventor Count = 14.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovative Contributions of Inventor Mingwei Chen in Glucagon Receptor Antagonism

Introduction

Mingwei Chen, an esteemed inventor based in San Diego, CA, is recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of five patents, Chen has focused his research on innovative compounds that target critical health conditions.

Latest Patents

Among his latest innovations, Chen has developed novel compounds that serve as antagonists of the glucagon receptor. His patent describes these compounds, classified under Formula (I), and their pharmaceutically acceptable salts and co-crystals. These compounds possess glucagon receptor antagonist or inverse agonist activity, which provides promising therapeutic avenues for treating, preventing, delaying the onset, or reducing the risk of Type I and II diabetes, insulin resistance, and hyperglycemia. Furthermore, the invention outlines the pharmaceutical compositions that incorporate these compounds, along with the processes for their synthesis.

Career Highlights

Mingwei Chen is currently associated with Metabasis Therapeutics, Inc., where he applies his expertise in drug development. His work focuses on advancing therapeutic options that address metabolic diseases, showcasing his dedication to improving patient health outcomes.

Collaborations

Throughout his career, Chen has had the opportunity to collaborate with notable professionals in his field. Notable coworkers include Jorge E. Gomez-Galeno and Paul D. Van Poelje, with whom he has shared insights and exchanged ideas to push the boundaries of pharmaceutical research and development.

Conclusion

Mingwei Chen's innovative work in glucagon receptor antagonism has the potential to make a substantial impact on the treatment of diabetes and related conditions. His dedication to research and collaboration highlights the importance of teamwork in advancing medical science, making him a noteworthy figure in the landscape of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…